Osteosarcoma  >>  sunitinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sunitinib / Generic mfg.
NCT00474994: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Completed
2
53
US
sunitinib malate
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), Dana-Farber Cancer Institute
Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor, Endometrial Cancer, Ovarian Cancer, Sarcoma, Small Intestine Cancer
11/10
11/10

Download Options